共 15 条
[1]
American Society of Hospital Pharmacists, 1993, AM J HOSP PHARM, V50, P305
[2]
INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1995, 274 (01)
:29-34
[3]
The costs of adverse drug events in hospitalized patients
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1997, 277 (04)
:307-311
[4]
COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG EVENTS IN HOSPITAL PATIENTS
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1991, 266 (20)
:2847-2851
[5]
Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1997, 277 (04)
:301-306
[6]
FOLLI HL, 1987, PEDIATRICS, V79, P718
[7]
JONVILLE APE, 1991, DICP ANN PHARMAC, V25, P1113
[8]
MULTIDISCIPLINARY PROGRAM FOR DETECTING AND EVALUATING ADVERSE DRUG-REACTIONS
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1989, 46 (09)
:1809-1812
[9]
KOREN G, 1986, PEDIATRICS, V77, P848
[10]
SYSTEMS-ANALYSIS OF ADVERSE DRUG EVENTS
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1995, 274 (01)
:35-43